Vaxcyte, Inc. (PCVX) has a consensus analyst rating of Buy, based on 11 analysts covering the stock. Of those, 11 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for PCVX is $83.00, representing a +32.2% upside from the current price of $62.76. Price targets range from a low of $77.00 to a high of $89.00.
